A panel of mesenchymal markers is more informative than a single antigen because expression can vary among cells from different tissue sources and under different culture conditions. Differentiation state also changes the profile. Evaluating several positive markers together therefore helps researchers characterize a population while reducing the risk that one variable marker will be treated as decisive.
Positive markers such as CD73, CD90, CD105, and vimentin provide evidence of mesenchymal characteristics, whereas negative markers help exclude hematopoietic or endothelial populations. This two-sided strategy is important because detecting a positive antigen alone may not establish that the analyzed cells belong to the intended population. Inclusion of exclusion markers improves the interpretive specificity of cellular characterization.
Marker expression should be interpreted in relation to cell state, not as a fixed identity label. Cells may show different profiles after changes in culture conditions or during differentiation, and tissue source can contribute additional variation. Consequently, mesenchymal markers are most useful when the experimental context is reported alongside the observed pattern, especially when comparing cell preparations.
Flow cytometry, immunostaining, and immunoblotting are distinct detection approaches listed for assessing these proteins and surface antigens. The important interpretive point is that the assay does not remove biological variability: whichever method is selected, researchers should evaluate marker combinations and account for tissue source, culture conditions, and differentiation state.
A practical workflow begins by selecting several commonly assessed positive markers, such as CD73, CD90, CD105, or vimentin, together with negative markers that exclude hematopoietic or endothelial cells. Researchers then choose flow cytometry, immunostaining, or immunoblotting for detection and interpret the resulting pattern in light of tissue source, culture conditions, and differentiation state.
In medicine, these markers support characterization of cells intended for tissue engineering and regenerative research, where confirming the cellular profile is important for interpreting experimental results. They also contribute to investigations of tumor progression and the tumor microenvironment. Their value extends beyond identification because marker patterns help researchers compare cell populations across experimental contexts.